BioSpace News Archive

Press Releases

SAGA Diagnostics® Announces U.S. Commercial Launch of Pathlight™ at ASCO 2025, Setting a New Standard for Ultra-sensitive and Early MRD Detection

May 27, 2025
·
6 min read
Press Releases

Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease

May 27, 2025
·
10 min read
Press Releases

Pion Inc. Announces DissoSpec Fully Integrated Dissolution System

May 27, 2025
·
2 min read
Press Releases

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 27, 2025
·
1 min read
Press Releases

Vetter Once Again Named Best Managed Company

May 27, 2025
·
1 min read
Press Releases

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June

May 27, 2025
·
2 min read
Press Releases

BioXcel Therapeutics Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

May 27, 2025
·
11 min read
Press Releases

Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Completion of Enrollment of the Global Phase 2b Study Evaluating Naronapride in Gastroparesis (MOVE-IT)

May 27, 2025
·
5 min read
Press Releases

START and OneOncology Partner To Expand Access to Early Phase Oncology Trials

May 27, 2025
·
4 min read
Press Releases

Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application (BLA) for MOLBREEVI* to Treat Patients With Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP)

May 27, 2025
·
6 min read